Skip to main content
. 2023 Jun 9;15(12):3130. doi: 10.3390/cancers15123130

Table 3.

Management of IBD patients with cancer history.

IBD Treatment Management
Withhold immunomodulation during active cancer therapy
Withhold thiopurines if bone marrow suppression is expected from the planned chemotherapy
Considerer avoiding immunomodulation in the first 2 years after cancer
Avoid combination therapy in cancer patients
Avoid JAK inhibitors in cancer patients